Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies - Hims & Hers Health stock tanks after FDA says competitor Eli Lilly's weight-loss drug shortage is over - Walmart, Aldi, and Kroger produce is under FDA recall - Novo Nordisk's once-weekly insulin is rejected by the FDA, in latest set back for the pharma giant - Lilly's Alzheimer's drug gets FDA nod - U.S. FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug - Dollar Tree left lead-tainted applesauce pouches on store shelves for weeks after recall, FDA says - Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug - FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval - Lilly's Alzheimer's drug that can slow disease gets backing from FDA advisers